Details.
A blood-based oxygen therapy using a true plasma separation filter to remove plasma containing toxins from mold, pesticides, airborne solvents and pollutants, inflammatory proteins, and autoimmune antibodies while simultaneously ozonating the blood. The procedure requires an IV in each arm, uses significantly less ozone than other EBOO-based procedures, and is described as beneficial for patients with multiple chemical sensitivities, complex chronic diseases including Lyme and Bartonella, histamine or MAST cell syndrome, post-vaccination injury, and post-COVID or long-haulers syndrome. The goal is to filter toxins, inflammatory proteins, and autoimmune antibodies from the plasma in an outpatient setting. Plasma extraction is 400 to 700 ml.
